Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc and copper in ALS
NCT01259050Phase 2Completed
- Sponsor
- Phoenix Neurological Associates
- Start
- Oct 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zinc in amyotrophic lateral sclerosis (ALS), sponsored by Phoenix Neurological Associates. Started Oct 2010; status: completed.
02
Drugs
zinc
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01259050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01259050.